Docusign Inc. (NASDAQ:DOCU) Given Average Recommendation of "Hold" by Brokerages

Key Points

• Docusign Inc. has received an average recommendation of "Hold" from 20 analysts, with 15 rating it as hold, four as buy, and one as strong buy.
• The shares of Docusign opened at $68.40, experiencing a decline of 4.1%, and the company has a market cap of $13.76 billion.
• In its latest quarterly earnings report, Docusign reported earnings of $0.92 EPS, exceeding expectations and showing an 8.8% increase in revenue year-over-year.

Shares of Docusign Inc. (NASDAQ:DOCU - Get Free Report) have received an average recommendation of "Hold" from the twenty analysts that are covering the company, MarketBeat.com reports. Fifteen research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating on the company. The average 1-year target price among analysts that have issued ratings on the stock in the last year is $94.1429.

Several analysts recently issued reports on the stock. Bank of America lifted their price target on shares of Docusign from $85.00 to $102.00 and gave the company a "neutral" rating in a research report on Friday, September 5th. Morgan Stanley lifted their price target on shares of Docusign from $86.00 to $90.00 and gave the company an "equal weight" rating in a research report on Monday, September 8th. Weiss Ratings reissued a "hold (c)" rating on shares of Docusign in a research report on Wednesday. Argus reissued a "hold" rating on shares of Docusign in a research report on Monday, September 8th. Finally, JPMorgan Chase & Co. lifted their price target on shares of Docusign from $77.00 to $80.00 and gave the company a "neutral" rating in a research report on Friday, September 5th.

Docusign Stock Down 4.1%

Shares of DOCU stock opened at $68.40 on Friday. The company has a market cap of $13.76 billion, a price-to-earnings ratio of 51.43, a price-to-earnings-growth ratio of 3.40 and a beta of 1.02. Docusign has a 52 week low of $66.35 and a 52 week high of $107.86. The firm has a 50 day moving average of $75.48 and a 200-day moving average of $78.45.

Docusign (NASDAQ:DOCU - Get Free Report) last announced its quarterly earnings data on Thursday, September 4th. The company reported $0.92 EPS for the quarter, topping the consensus estimate of $0.84 by $0.08. The company had revenue of $800.64 million during the quarter, compared to the consensus estimate of $780.35 million. Docusign had a net margin of 9.08% and a return on equity of 14.01%. The company's quarterly revenue was up 8.8% on a year-over-year basis. During the same quarter last year, the firm posted $0.97 EPS. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. Analysts anticipate that Docusign will post 1.17 earnings per share for the current year.

Insider Buying and Selling at Docusign

In other Docusign news, Director Peter Solvik sold 15,000 shares of the firm's stock in a transaction on Monday, September 15th. The stock was sold at an average price of $81.48, for a total transaction of $1,222,200.00. Following the transaction, the director directly owned 135,253 shares in the company, valued at approximately $11,020,414.44. This trade represents a 9.98% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider James P. Shaughnessy sold 7,500 shares of the firm's stock in a transaction on Wednesday, October 1st. The shares were sold at an average price of $71.19, for a total value of $533,925.00. Following the transaction, the insider owned 55,442 shares in the company, valued at approximately $3,946,915.98. This trade represents a 11.92% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 102,533 shares of company stock worth $7,709,933. 1.01% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Docusign

Several large investors have recently bought and sold shares of the stock. Lifestyle Asset Management Inc. lifted its stake in Docusign by 33.8% during the 3rd quarter. Lifestyle Asset Management Inc. now owns 17,496 shares of the company's stock valued at $1,261,000 after acquiring an additional 4,419 shares in the last quarter. Board of the Pension Protection Fund raised its stake in shares of Docusign by 9.0% during the 3rd quarter. Board of the Pension Protection Fund now owns 19,300 shares of the company's stock worth $1,391,000 after purchasing an additional 1,600 shares during the period. Mitchell & Pahl Private Wealth LLC raised its stake in shares of Docusign by 0.7% during the 3rd quarter. Mitchell & Pahl Private Wealth LLC now owns 21,422 shares of the company's stock worth $1,544,000 after purchasing an additional 149 shares during the period. Bennett Selby Investments LP raised its stake in shares of Docusign by 10.1% during the 3rd quarter. Bennett Selby Investments LP now owns 7,790 shares of the company's stock worth $562,000 after purchasing an additional 715 shares during the period. Finally, ST Germain D J Co. Inc. raised its stake in shares of Docusign by 29.3% during the 3rd quarter. ST Germain D J Co. Inc. now owns 2,205 shares of the company's stock worth $159,000 after purchasing an additional 500 shares during the period. 77.64% of the stock is currently owned by institutional investors.

About Docusign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.